Circulatory support for shock complicating myocardial infarction

Journal of Invasive Cardiology

Volumn 26, Issue 8, 2014, Pages

  Acharya, Deepak ^a   Loyaga Rendon, Renzo Y ^a   Tallaj, Jose A ^a   Pamboukian, Salpy V ^a   Sasse, Mark F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AMI; cardiogenic shock; Impella CP

Indexed keywords

GLYCERYL TRINITRATE; MILRINONE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CASE REPORT; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; ELECTROCARDIOGRAM; EPIGASTRIC DISCOMFORT; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAAORTIC BALLOON PUMP; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT VENTRICULAR ASSIST DEVICE; MALE; MITRAL VALVE REGURGITATION; PERCUTANEOUS CORONARY INTERVENTION; RIGHT CORONARY ARTERY; SWAN GANZ CATHETER; THORAX PAIN; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; CORONARY ANGIOGRAPHY; ECHOENCEPHALOGRAPHY; ELECTROCARDIOGRAPHY; HEART ASSIST DEVICE; HEMODYNAMICS; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; ECHOENCEPHALOGRAPHY; ELECTROCARDIOGRAPHY; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84905501425     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341(9):625-634.
2. Babaev A, Frederick PD, Pasta DJ, et al; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294(4):448-454.
3. Fox KA, Steg PG, Eagle KA, et al; GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297(17):1892-1900.
4. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guidelines for the management of STelevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;127(4):529-555.
5. Barron HV, Every NR, Parsons LS, et al; Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141 (6):933-939.
6. Christenson JT, Simonet F, Badel P, Schmuziger M. Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg. 1997;11(6):1097-1103.
7. Christenson JT, Badel P, Simonet F, Schmuziger M. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg. 1997;64(5):1237-1244.
8. Sá MP, Ferraz PE, Escobar RR, et al. Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass surgery: A meta-analysis of randomized controlled trials. Coron Artery Dis. 2012;23(7):480-486.
9. Gold HK, Leinbach RC, Sanders CA, et al. Intraaortic balloon pumping for ventricular septal defect or mitral regurgitation complicating acute myocardial infarction. Circulation. 1973;47(6):1191-1196.
10. Sjauw KD, Engström AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: Should we change the guidelines? Eur Heart J. 2009;30(4):459-468.
11. Bahekar A, Singh M, Singh S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: A meta-analysis. J Cardiovasc Pharmacol Ther. 2012;17(1):44-56.
12. Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: A comprehensive meta-analysis. Am Heart J. 2013;165(5):679-692.
13. Thiele H, Zeymer U, Neumann FJ, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-1296.
14. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584-1588.
15. Lauten A, Engström AE, Jung C, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: Results of the Impella-EUROSHOCK-registry. Circ Heart Fail. 2013;6 (1):23-30.
16. Engström AE, Cocchieri R, Driessen AH, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience. Crit Care Med. 2011;39(9):2072-2079.
17. Impella CP Instructions for Use and Clinical Reference Manual. p. 5.19. Accessed 12/3/2013.
18. http://www.abiomed.com/assets/AIC-2-5-IFU-Rev-G.pdf. Accessed 12/3/2013.
19. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.e1-e8.
20. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276-1283.
21. Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57(6):688-696.
22. Hill JD, Farrar DJ, Hershon JJ, et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med. 1986;314(10):626-628.
23. Farrar DJ, Lawson JH, Litwak P, et al. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant. 1990;9(4):415-422.
24. Chen JM, DeRose JJ, Slater JP, et al. Improved survival rates support left ventricular assist device implantation early after myocardial infarction. J Am Coll Cardiol. 1999;33(7):1903-1908.
25. Park SJ, Nguyen DQ, Bank AJ, et al. Left ventricular assist device bridge therapy for acute myocardial infarction. Ann Thorac Surg. 2000;69(4):1146-1151.
26. Entwistle JW 3rd, Bolno PB, Holmes E, Samuels LE. Improved survival with ventricular assist device support in cardiogenic shock after myocardial infarction. Heart Surg Forum. 2003;6(5):316-319.
27. Gray LA Jr, Champsaur GG. The BVS 5000 biventricular assist device. The worldwide registry experience. ASAIO J. 1994;40(3):M460-M464.
28. Anderson M, Smedira N, Samuels L, et al. Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg. 2010;90(3):706-712.
29. Leshnower BG, Gleason TG, O'Hara ML, et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg. 2006;81(4):1365-1370.
30. Pawale A, Pinney S, Ashley K, et al. Implantable left ventricular assist devices as initial therapy for refractory postmyocardial infarction cardiogenic shock. Eur J Cardiothorac Surg. 2013;44(2):213-216. Epub 2013 Jan 30
31. Jaski BE, Lingle RJ, Overlie P, et al. Long-term survival with use of percutaneous extracorporeal life support in patients presenting with acute myocardial infarction and cardiovascular collapse. ASAIO J. 1999;45(6):615-618.
32. Bermudez CA, Rocha RV, Toyoda Y, et al. Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy. Ann Thorac Surg. 2011;92(6):2125-2131.
33. Kim H, Lim SH, Hong J, et al. Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation. 2012;83(8):971-975.
34. Chung SY, Sheu JJ, Lin YJ, et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study. Circ J. 2012;76(6):1385-1392.
35. Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med. 2010;38(9):1810- 1817.
36. Hoefer D, Ruttmann E, Poelzl G, et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg. 2006;82(1):28-33.
37. Tayara W, Starling RC, Yamani MH, et al. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: Comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006;25(5):504-509.
38. http://www.uab.edu/medicine/intermacs/images/Federal-Quarterly-Report/ Federal-Partners-Report-2012-Q4.pdf. Accessed 6/19/2013